Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2014

Open Access 01-12-2014 | Research article

Use of bodily sensations as a risk assessment tool: exploring people with Multiple Sclerosis’ views on risks of negative interactions between herbal medicine and conventional drug therapies

Authors: Lasse Skovgaard, Inge Kryger Pedersen, Marja Verhoef

Published in: BMC Complementary Medicine and Therapies | Issue 1/2014

Login to get access

Abstract

Background

Most users of complementary and alternative medicine (CAM) combine it with conventional medicine. Recent risk assessment studies have shown risks of negative interactions between CAM and conventional medicine, particularly when combining herbal medicine and conventional drug therapies (CDT). Little is known about the way users consider such risks. The present paper aims to gain knowledge about this issue by exploring views on risks of negative interactions when combining herbal medicine and CDT among people with multiple sclerosis (MS).

Methods

This paper draws on a qualitative follow-up study on a survey among members of the Danish MS Society. Semi-structured, in-depth qualitative interviews were conducted with a strategic selection from the survey respondents. The study was inspired by a phenomenological approach and emerging themes were extracted from the data through meaning condensation.

Results

Four themes characterized the informants’ views on risks of negative interactions when combining herbal medicine and CDT: 1) ‘naturalness’ in herbal medicine; 2) ‘bodily sensations’ as guidelines; 3) trust in the CAM practitioner; 4) lack of dialogue with medical doctor.

Conclusions

Generally, the combination of herbal medicine and CDT was considered by the informants to be safe. In particular, they emphasized the ‘non-chemical’ nature of herbal medicine and of their own bodily sensations as warrants of safety. A trustful relation to the CAM practitioner furthermore made some of them feel safe in their use of herbal medicine and CDT in combination. The informants’ use of bodily sensations as a non-discursive risk assessment may be a relevant element in understanding these issues.
Literature
1.
Olsen SA: A review of complementary and alternative medicine (CAM) by people with multiple sclerosis. Occup Ther Int. 2009, 16 (1): 57-70. 10.1002/oti.266.CrossRefPubMed
2.
Bowling AC: Complementary and alternative medicine and multiple sclerosis. Neurol Clin. 2011, 29 (2): 465-480. 10.1016/j.ncl.2010.12.006.CrossRefPubMed
3.
Hussain-Gambles MTP: The experience of complementary alternative medicine use among people with multiple sclerosis. Complement Health Pract Rev. 2004, 9 (1): 21-30.
4.
Nayak S, Matheis RJ, Schoenberger NE, Shiflett SC: Use of unconventional therapies by individuals with multiple sclerosis. Clin Rehab. 2003, 17 (2): 181-191. 10.1191/0269215503cr604oa.CrossRef
5.
Apel-Neu A, Zettl UK: Complementary and alternative medicine in multiple sclerosis. J Neurol. 2008, 255 (Suppl 6): 82-86.CrossRefPubMed
6.
Leong EM, Semple SJ, Angley M, Siebert W, Petkov J, McKinnon RA: Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why?. Complement Ther Med. 2009, 17 (4): 216-223. 10.1016/j.ctim.2009.03.001.CrossRefPubMed
7.
Apel A, Greim B, Konig N, Zettl UK: Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis. J Neurol. 2006, 253 (10): 1331-1336. 10.1007/s00415-006-0217-9.CrossRefPubMed
8.
Giveon SM, Liberman N, Klang S, Kahan E: Are people who use “natural drugs” aware of their potentially harmful side effects and reporting to family physician?. Patient Educ Couns. 2004, 53 (1): 5-11. 10.1016/S0738-3991(03)00241-6.CrossRefPubMed
9.
Campbell DG, Turner AP, Williams RM, Hatzakis M, Bowen JD, Rodriquez A, Haselkorn JK: Complementary and alternative medicine use in veterans with multiple sclerosis: prevalence and demographic associations. J Rehabil Res Dev. 2006, 43 (1): 99-110. 10.1682/JRRD.2004.08.0110.CrossRefPubMed
10.
Skovgaard L, Nicolajsen PH, Pedersen E, Kant M, Frederikson S, Verhoef MJ, Meyrowitsch DW: Use of complementary and alternative medicine among people with multiple sclerosis in the Nordic Countries. Auto Dis. 2012, 2012 (Article ID 841085): 13-
11.
Skovgaard L, Nicolajsen PH, Pedersen E, Kant M, Frederikson S, Verhoef MJ, Meyrowitsch DW: People with Multiple Sclerosis in Denmark who use complementary and alternative medicine - do subgroups of patients differ?. Eur J Integrat Med. 2013, 41 (5): 492-499.
12.
Izzo AA, Ernst E: Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009, 69 (13): 1777-1798. 10.2165/11317010-000000000-00000.CrossRefPubMed
13.
Low J: Managing safety and risk: the experiences of people with Parkinson’s disease who use alternative and complementary therapies. Health. 2004, 8 (4): 445-463.PubMed
14.
Pedersen IK: ‘It can do no harm’: body maintenance and modification in alternative medicine acknowledged as a non risk health regimen. Soc Sci Med. 2013, 90 (2013): 56-62.CrossRefPubMed
15.
Dergal JM, Gold JL, Laxer DA, Lee MS, Binns MA, Lanctot KL, Freedman M, Rochon PA: Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging. 2002, 19 (11): 879-886. 10.2165/00002512-200219110-00005.CrossRefPubMed
16.
Marchisio P, Bianchini S, Galeone C, Baggi E, Rossi E, Albertario G, Torretta S, Pignataro L, Esposito S, Principi N: Use of complementary and alternative medicine in children with recurrent acute otitis media in Italy. Int J Immunopathol Pharmacol. 2011, 24 (2): 441-449.PubMed
17.
Creswell JW, Clark VLP: Designing and conducting Mixed Methods Research. 2011, London: Sage Publications
18.
Skovgaard L, Nicolajsen PH, Pedersen E, Kant M, Fredrikson S, Verhoef M, Meyrowitsch D: Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: a comparison of descriptive characteristics. Scand J Public Health. 2013, 41 (5): 492-499. 10.1177/1403494813481646.CrossRefPubMed
19.
Skovgaard L, Nicolajsen PH: Investigating different groups of CAM users among members with multiple sclerosis of The Danish MS Society. Eur J Integeated Med. 2012, 4 (Supplement Issue, 09.2012): 174-175.
20.
Creswell JW: Qualitative Inquiry and Research Design: Choosing Among Five Traditions. 2007, California: Sage Publications
21.
Patton MQ: Qualitative Evaluation Methods. 2002, London: Sage Publications
22.
Fade S: Using interpretative phenomenological analysis for public health nutrition and dietetic research: a practical guide. Proc Nutr Soc. 2004, 63 (4): 647-653. 10.1079/PNS2004398.CrossRefPubMed
23.
Smith JA, Flowers P, Osborn M: Interpretative phenomenological analysis and the psychology of health and illness. L Y, editor. 1997, London: Routledge
24.
Hycner RH: Some guidelines for the phenomenological analysis of interview data. Hum Stud. 1985, 8: 279-303. 10.1007/BF00142995.CrossRef
25.
Kvale S: Interviews - an introduction to qualitative research interviewing. 1996, London: Sage Publications
26.
Paterson C, Baarts C, Launso L, Verhoef MJ: Evaluating complex health interventions: a critical analysis of the ‘outcomes’ concept. BMC Complement Altern Med. 2009, 9: 18-10.1186/1472-6882-9-18.CrossRefPubMedPubMedCentral
27.
Rogers P: Using programme theory to evaluate complicated and complex aspects of interventions. Evaluation. 2008, 14: 29-48. 10.1177/1356389007084674.CrossRef
28.
Skovgaard L, Bjerre L, Haahr N, Paterson C, Launsø L, Boesen F, Nissen M, Ottesen MB, Mortensen C, Olsen A, Borch S, Mortensen BK, Rasmussen GA, Sietam K, Staalkjær F, Pedersen K, Søndermark K: An investigation of multidisciplinary complex health care interventions - steps towards an integrative treatment model in the rehabilitation of People with Multiple Sclerosis. BMC Complement Altern Med. 2012, 12 (1): 50-10.1186/1472-6882-12-50.CrossRefPubMedPubMedCentral
29.
Launso L, Skovgaard L: The IMCO scheme as a tool in developing team-based treatment for people with multiple sclerosis. J Altern Complement Med. 2008, 14 (1): 69-77. 10.1089/acm.2007.0593.CrossRefPubMed
30.
Connor LH: Relief, risk and renewal: mixed therapy regimens in an Australian suburb. Soc Sci Med. 2004, 59 (8): 1695-1705. 10.1016/j.socscimed.2004.01.030.CrossRefPubMed
31.
Marignani M, Gallina S, Di Fonzo M, Deli I, Begini P, Gigante E, Epifani M, Angeletti S, Delle Fave G: Use and safety perception of herbal remedies in patients with liver/biliary tract disorders: an Italian study. J Clin Gastroenterol. 2010, 44 (Suppl 1): S54-S57.CrossRefPubMed
32.
Wagner PJ, Jester D, LeClair B, Taylor AT, Woodward L, Lambert J: Taking the edge off: why patients choose St, John’s Wort. J Fam Pract. 1999, 48 (8): 615-619.PubMed
33.
George J, Ioannides-Demos LL, Santamaria NM, Kong DC, Stewart K: Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease. Med J Aust. 2004, 181 (5): 248-251.PubMed
34.
Cassidy A: Are herbal remedies and dietary supplements safe and effective for breast cancer patients?. Breast Cancer Res. 2003, 5 (6): 300-302. 10.1186/bcr724.CrossRefPubMedPubMedCentral
35.
Baarts C, Pedersen IK: Derivative benefits: exploring the body through complementary and alternative medicine. Sociol Health Illn. 2009, 31 (5): 719-733. 10.1111/j.1467-9566.2009.01163.x.CrossRefPubMed
36.
Sointu E: The search for wellbeing in alternative and complementary health practices. Sociol Health Illn. 2006, 28 (3): 330-349. 10.1111/j.1467-9566.2006.00495.x.CrossRefPubMed
37.
Truant T, Bottorff JL: Decision making related to complementary therapies: a process of regaining control. Patient Educ Couns. 1999, 38 (2): 131-142. 10.1016/S0738-3991(99)00060-9.CrossRefPubMed
38.
Salamonsen A, Launso L, Kruse TE, Eriksen SH: Understanding unexpected courses of multiple sclerosis among patients using complementary and alternative medicine: a travel from recipient to explorer. Int J Qual Stud Health Well-being. 2010, 5: 5032-CrossRef
39.
Kruse T: Sygdomsfortolkning og historiebrug. Et patientperspektiv på årsager til sygdom og veje til helbredelse [Interpreting disease and patients’ narratives. A patient’s perception of the causes of disease and paths to cure. In Danish]. Bibliotek for læger. 2009, 201 (4): 232-458.
40.
Heggdal K: Kroppskunnskaping – pasienten som ekspert i helsefremmende prosesser [Body-knowledge – the patient as expert in health-promoting processes. In Norwegian]. 2008, Gyldendal Akademisk: Oslo
41.
Skovgaard L, Pedersen IK, Verhoef M: Exclusive use of alternative medicine as a positive choice. Exploring treatment assumptions among people with MS in Denmark. Int J MS Care. 2013, In press
42.
Chrysanthou M: Transparency and selfhood: utopia and the informed body. Soc Sci Med. 2002, 54: 469-479. 10.1016/S0277-9536(01)00033-8.CrossRefPubMed
43.
Murphy SM, Rogers A, Hutchinson M, Tubridy N: Counting the cost of complementary and alternative therapies in an Irish neurological clinic. Eur J Neurol. 2008, 15 (12): 1380-1383. 10.1111/j.1468-1331.2008.02320.x.CrossRefPubMed
44.
Vickers KA, Jolly KB, Greenfield SM: Herbal medicine: women’s views, knowledge and interaction with doctors: a qualitative study. BMC Complement Altern Med. 2006, 6: 40-10.1186/1472-6882-6-40.CrossRefPubMedPubMedCentral
45.
Samkoff LM, Goodman AD: Symptomatic management in multiple sclerosis. Neurol Clin. 2011, 29 (2): 449-463. 10.1016/j.ncl.2011.01.008.CrossRefPubMed
Metadata
Title
Use of bodily sensations as a risk assessment tool: exploring people with Multiple Sclerosis’ views on risks of negative interactions between herbal medicine and conventional drug therapies
Authors
Lasse Skovgaard
Inge Kryger Pedersen
Marja Verhoef
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2014
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-14-59

Other articles of this Issue 1/2014

BMC Complementary Medicine and Therapies 1/2014 Go to the issue

Research article

Studies on antidiarrhoeal, antispasmodic and bronchodilator activities of Operculina turpethum Linn

Research article

Correlation of antiangiogenic, antioxidant and cytotoxic activities of some Sudanese medicinal plants with phenolic and flavonoid contents

Research article

In vitro and ex-vivo cellular antioxidant protection and cognitive enhancing effects of an extract of Polygonum minus Huds (Lineminus™) demonstrated in a Barnes Maze animal model for memory and learning

Study protocol

Assessing the comparative effectiveness of Tai Chi versus physical therapy for knee osteoarthritis: design and rationale for a randomized trial

Research article

Mozart K.448 listening decreased seizure recurrence and epileptiform discharges in children with first unprovoked seizures: a randomized controlled study

Research article

Essential oil of Pinus koraiensis inhibits cell proliferation and migration via inhibition of p21-activated kinase 1 pathway in HCT116 colorectal cancer cells